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Abstract Functional abdominal pain and irritable bowel
syndrome are two prevalent disorders in childhood which
are associated with recurrent or chronic abdominal pain,
disabilities in daily functioning, and reduced quality of life.
This study aimed to evaluate a brief hypnotherapeutic-
behavioral intervention program in a prospective random-
ized controlled design. Thirty-eight children, 6 to 12 years
of age, and their parents were randomly assigned to a stan-
dardized hypnotherapeutic–behavioral treatment (n=20) or to
a waiting list condition (n=18). Both groups were reassessed
3 months after beginning. Primary outcome variables were
child-completed pain measures and pain-related disability.
Secondary outcome variables were parent-completed mea-
sures of their children's pain and pain-related disability.
Health-related quality of life from both perspectives also
served as a secondary outcome. In the treatment group, 11 of
20 children (55.0 %) showed clinical remission (>80 % im-
provement), whereas only one child (5.6 %) in the waiting list
condition was classified as responder. Children in the
treatment group reported a significantly greater reduc-
tion of pain scores and pain-related disability than chil-
dren of the waiting list condition. Parental ratings also
showed a greater reduction of children's abdominal pain
and pain-related disability. Health-related quality of life did
not increase significantly. Conclusions: Hypnotherapeutic and
behavioral interventions are effective in treating children with
long-standing AP. Treatment success of this brief program
should be further evaluated against active interventions with
a longer follow-up.
Keywords Functional abdominal pain . Irritable bowel
syndrome . Children . Hypnotherapy . Randomized–
controlled trial
Introduction
Recurrent or chronic abdominal pain (AP) is the most preva-
lent pain syndrome in childhood [15, 42, 45]. Because of the
predominant absence of organic diseases [1, 54], the recurring
occurrence of AP is mostly classified as a functional gastro-
intestinal disorder (FGID) [39]. Functional abdominal pain
(FAP) and irritable bowel syndrome (IBS) are the most fre-
quent FGIDs in childhood [10, 23] and are characterized by
recurrent or continuous AP for at least 2 months [39]. IBS is
additionally accompanied by changes in defecation (diarrhea
and/or constipation) and/or relief of symptoms after defeca-
tion [39]. In the past, many studies did not use coherent criteria
and did not distinguish between different symptom patterns
such as FAP or IBS. This contributed to inconsistent preva-
lence rates in the range between 1 and 19 % [7].
A considerable portion of visits in doctors' offices is
caused by cases of AP of undetermined origin [29, 44].
Frequent AP is associated with substantial disabilities in
quality of life and daily functioning [59], particularly in
attending school [29, 38]. A part of children with AP is at
risk of symptom persistence till adulthood [5, 21, 24, 53].
Children with AP are found to score higher in question-
naires assessing psychopathological symptoms especially
internalizing disturbances such as anxiety and other somatic
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complaints [14, 17, 52]. They also feature a high rate of
psychiatric disorders such as anxiety disorders and depres-
sion [4, 36]. Beyond psychological symptoms, a few studies
report abnormalities in the function of the gut in terms of a
heightened sensitivity of the gut [12] and modified gut
motility [46].
Whereas dietary and pharmacological interventions are
lacking in high quality evidence [26, 28], cognitive–behav-
ioral interventions seem to be effective [27, 35]. Derived
from good evidence in treating adults with long-standing
IBS with hypnotherapy (HT) [16, 18, 58], this might also be
a promising approach in handling FAP and IBS in childhood
[47–49]. The most comprehensive study in HT treatment of
FAP and IBS in children and adolescents (8–18 years) by a
Dutch workgroup [48, 49] could demonstrate that HT was
highly superior to standard medical care, even in a long-
term follow-up. A study in the United States was able to
show that self-administered audio-recorded HT for children
and adolescents with FAP (6–15 years) was superior to a
waiting list condition [47]. The employment of standardized
psychotherapeutic interventions in childhood FGIDs is not
common in Germany [20, 44]. Therefore, we conducted a
brief intervention program based on hypnotherapeutic and
behavioral methods. With this concept, we focused on chil-
dren aged 6 to 12. Preliminary results showed encouraging
effects regarding pain characteristics and daily functioning
[22]. The current study aimed on evaluating this interven-
tion program in a prospective randomized controlled design,
comparing a treatment group (TG) with a wait-list control
group (WCG) three months after beginning.
Materials and methods
Study participants
Children had to be between 6 and 12 years of age. Inclusion
criteria for the study were based on the Rome III definition
of FAP and IBS. For participation, children had to feature
recurrent or continuous AP for at least 2 months occurring at
least once a week. In case of IBS, AP had to be associated
additionally with two or more of the following at least 25 %
of the time: (1) improved with defecation, (2) onset associ-
ated with a change in frequency of stool, (3) onset associat-
ed with a change in form (appearance) of stool. A
confirmation about the absence of organic diseases had been
collected from the attending pediatrician or gastroenterolo-
gist. Exclusion criteria for the study were (1) ongoing spe-
cific treatment by another health care specialist (physician or
psychotherapist) and (2) fulfilled criteria for functional dys-
pepsia or abdominal migraine.
Participant families were recruited from public announce-
ments in local newspapers and at pediatricians' offices. The
intervention was conducted at a university psychotherapeutic
outpatient clinic. Fifty-four interested families were screened
for eligibility, and 38 families (70.4 %) finally entered the trial.
Reasons for exclusion of participants were nonfulfillment of
diagnostic criteria (n=8) and refusal of participation (n=7).
One family was excluded due to very bad German language
skills. Remaining 38 participant families were randomly
assigned following simple randomization procedures (com-
puterized random number generator) to TG (n=20) or WCG
(n=18). Details on recruiting are illustrated in Fig. 1.
All families gave informed consent to participate in the
study. The study had been approved by the ethics committee
of the University Hospital Tübingen.
Treatment
The treatment program [22, 43] consisted of four group ses-
sions which split up in two children sessions and two parent
sessions in a weekly sequence. Group size was between four
and seven families. The treatment program was strictly stan-
dardized by a manual, and participants also received written
information. Each treatment session lasted 90 min and was
conducted by trained psychologists. The two sessions for the
children addressed their abilities for self-instruction, relaxa-
tion, imagination, and provided information about the link
between stress and AP. Both sessions included standardized
hypnotherapeutic trances which aimed at increased well-
being, the ability of being brave, and the ability of managing
the pain (closing the “pain gate”). Children were instructed to
practice these trances, recorded on a CD, at home for 4 weeks
at least five times a week (each 15–20 min). The two sessions
for the parents comprised of information about FGIDs and
their link to anxiety and stress, the individual identification of
triggers, and information about positive educational strategies
respective operant learning mechanisms in terms of secondary
gain.
Measures
Children and their parents in the TG filled out question-
naires before the start of the treatment. The treatment lasted
for 4 weeks. Two months after ending the treatment
(3 months after the start), the participants were reassessed.
Participant families in the WCG filled out questionnaires
before the start of the waiting time and 3 months after the
start of the waiting time.
Baseline measures
The Child Behavior Checklist 4/18 (CBCL) [6] consists of
113 behavior and emotional problems during the previous
6 months which were rated by the parents as being not true,
sometimes or somewhat true, or very or often true. The
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CBCL is a widely used and well validated screening instru-
ment for children's psychopathology [32]. We employed the
three major scores of internalizing difficulties, externalizing
difficulties, and total difficulties. The CBCL was only used
for baseline comparisons of children's psychopathology and
was therefore not included in the follow-up measurement.
Primary outcome measures
Because of the risk of possible underreporting, measurement
of pain should be obtained directly from the children and serve
as primary outcome variable [2]. Participating children kept a
pain diary for 2 weeks at both measurement points. The pain
diary recorded the number of days with AP, the mean inten-
sity, and the mean duration of pain episodes. It was also
assessed whether the child missed school because of AP. Pain
intensity was rated on a numeric rating scale from 1 to 10
(“very little pain” to “the most pain possible”). The duration of
AP was scored as: 0 = no pain, 1 = a few minutes, 2 = about
half an hour, 3 = about an hour, 4 = between 1 and 2 h, 5 = 3 or
4 h, 7 = most of the day and 8 = all day (it never completely
stops). The classification of pain duration was taken over from
the widely used abdominal pain index (API) [55].
The Rome expert panel recommended that in trials for
FGIDs, one primary outcome measure should be the per-
centage of subjects meeting a predetermined clinical out-
come [30]. For this purpose, we calculated an additive index
of AP based on the three pain ratings of the pain diary
(days with pain + pain duration + pain intensity). Because
of the different scaling of the three pain ratings, the index of
AP is calculated from standardized z values. This procedure
considers various symptom patterns (e.g., scarce but
Assessed for eligibility (n=54) 
Excluded (n=16) 
 Not meeting inclusion criteria (n=8) 
- Pain frequency too low (n=3) 
- Pain onset <2 months (n=1) 
- Diagnosis of abdominal migraine (n=1) 
- No prior medical examination (n=2) 
- Child was too young (n=1) 
 Declined to participate (n=7) 
- No reason stated (n=2) 
- Declined to fill out questionnaires (n=1) 
- Reservations about hypnotherapy (n=1) 
- Complaints got better spontaneously (n=2) 
- Child was too afraid to attend (n=1) 
 Parents had very bad German language 
skills (n=1) 
Analysed (n=20) 
No participant excluded
 Discontinued intervention (n=1) 
- n=1 family missed one parent session and received only 
written information 
 No lost to follow-up 
Allocated to TG (n=20) 
 No lost to follow-up 
Allocated to WCG (n=18) 
Analysed (n=18) 
No participant excluded
Allocation
Analysis
Measurement  
3 months after 
beginning 
Randomized (n=38) 
Enrollment 
Fig. 1 Flow diagram of study participants
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intensive AP or frequent but weak AP) and is similar to the
API [55]. In many studies, a 50 % symptom improvement is
considered to be a reasonable definition of a treatment
responder [8], but we applied a more conservative categori-
zation, which was also used in a previous trial addressing
childhood FGIDs [48, 49]. Participating children with
>80 % improvement of the index were considered as re-
sponders with a clinical remission. An improvement be-
tween 30–80 % was defined as “significant improvement.”
The treatment was considered to be unsuccessful if the
scores improved only <30 % or got worse.
The self-reported pain-related disability was assessed by
the one-dimensional pediatric-pain disability index (P-PDI)
[25]. The P-PDI assesses pain-related impairment in 12 daily
activities, with each ranging from 1 = never to 5 = always. The
self-report featured good internal consistency (α=.87) [25]. In
our sample, we found an internal consistency of α=.85.
Secondary outcome measures
Parents were asked to rate their children's AP with the parental
form of the five-item abdominal pain index (API) [55]. The
API assessed the frequency of AP within the last 2 weeks on a
6-point scale from “not at all” to “every day.” The daily
frequency was also rated on a 6-point scale from “none” to
“constant during the day.”Usual duration of a pain episode was
rated on a 9-point scale from “none” to “all day.” The usual
intensity of a pain episode and the maximum intensity were
scored using two 10-point scales ranging from “no pain” to “the
most pain possible.”Because of the different answer formats of
the five pain ratings, the variables were z-standardized and
added up to provide a balanced index of AP. Previous studies
[55] have shown adequate internal consistency of the API (α
=.80–93), which could be confirmed in our sample (α=.87).
As a secondary outcome, the P-PDI was also adminis-
tered to the parents. The parent-completed P-PDI is parallel
to the previously described children version. In our sample,
the internal consistency of the parental report was α=.84.
Health-related quality of life (HRQoL) is recommended as
secondary outcome in trials for the treatment of FGIDs [30]. It
was assessed in children using the revised German KINDL
questionnaire [40], which exhibits three age versions. The
KINDL is a well validated measure of HRQoL [40, 41]. We
applied theKINDL-Kiddy (age4–7years) and theKINDL-Kid
(8–12 years) with both parental and self-appraisals. The
KINDL-Kid consists of 24 items and the KINDL-Kiddy of
22 items, each ranging from 1 = never to 5 = always. The total
score ranges from0 (lowest HRQoL) to 100 (highestHRQoL).
Statistics
Baseline differences between the two groups were examined
using χ2 tests for frequencies and t tests for data based on
means. When normal distribution could not be assumed,
Mann–Whitney U test was used for comparisons between
means. Mann–Whitney U test was also used for comparing
ordinal scaled data. Changes from pre to post were calcu-
lated with univariate repeated-measures ANOVAs. Depen-
dent variables yielding univariate significance were included
in two repeated-measures MANOVAs (one for children's and
one for parent's perspective) to control for interactions among
the dependent variables and multiple testing. In case of supe-
riority of one treatment group, we expected significant time ×
group interactions in (M)ANOVAs. (M)ANOVA effect sizes
are reported as η2 (small effect η2=0.01, medium effect
η2=0.06, strong effect η2=0.14). All tests were two-tailed,
and the significance level was set at p<0.05. Based on our
previous results [22], we expectedmedium effect sizes regard-
ing the time × group interactions. To ensure medium effects
with a power of .80, at least 34 children (17 per group) had to
be included in the trial. Statistical analyses were performed
using SPSS (version 20).
Results
A total of 38 children and their parents entered the trial. The
sample consisted of 24 girls (63.2 %) and 14 boys (36.8 %)
with a mean age of M=9.37 years (SD=1.72). An amount of
29 children, 76.3 % of the sample, fulfilled criteria for FAP,
and 9 children were diagnosed to have IBS (23.7 %). On
average, the onset of complaints was 34.6 months ago
(SD=40.41; 2.9 years).
As reported in Table 1, there were no differences
between the TG and WCG after randomization. TG
and WCG did not differ with regard to demographic
characteristics, pain characteristics, or behavioral and
emotional problems (CBCL).
Primary outcomes
Children in the TG reported a greater reduction of days with
AP compared to children in the WCG, which is supported
by a significant time × group interaction (F=4.25, p=.046,
η2=.106). At follow-up, children in the TG reported 1.8
pain days during the diary period of 2 weeks (decrease of
6.1 days) whereas children in the WCG reported 6.2 days
(decrease of 3.3 days). Children's reports of mean intensity
of pain episodes decreased significantly stronger in the TG
than in the WCG group (F=8.27, p=.007, η2=.187) from
4.2 points to 1.6 points, respectively, 5.0 points to 4.5 points
(scaled from 1 to 10). Mean duration of pain episodes also
shortened significantly more in the TG group (F=6.57,
p=.015, η2=.154). As missing school was reported sel-
dom at baseline and at follow-up, no sound calculation
could be carried out. Pain-related disability as reported
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by the children improved from baseline to post-
measurement in the TG; whereas, it remained stable in
the WCG (F=6.73, p=.014, η2=.161).
The responder analysis was based on an additive index of
AP derived from the children's pain diaries. In the TG 11 of
20 children (55.0 %) showed clinical remission (>80 %
improvement), whereas only one child (5.6 %) in the
WCG was classified as responder (p=.002). Five children
(25.0 %) in the TG and five children in the WCG (27.8 %)
showed a significant symptom improvement between 30–
80 %. Four children of the TG (20.0 %) and 12 children
(66.7 %) of the WCG did not improve or got worse.
Secondary outcomes
Parent's reports of AP symptoms were measured using the
API. From baseline to follow-up, univariate analysis re-
vealed a significantly stronger reduction of symptoms in
the TG (F=7.57, p=.009, η2=.174). Pain-related disability
as reported by the parents also improved significantly more
in the TG (F=7.27, p=.011, η2=.168).
Self-reported HRQoL improved in the TG and not in the
WCG at follow-up, but the interaction between group and
time factor failed to reach significance (F=2.56, p=.120).
Parental rating of HRQoL improved in both conditions
and showed no differential effect between the two
groups (F=0.18, p=.678).
Multivariate analysis for child-completed and parent-
completed measures
An additional repeated-measures MANOVA which in-
cluded the three child-completed pain parameters and
the pain-related disability demonstrated that all four
parameters still reached significance regarding the time ×
group interaction, indicating a superiority of the TG from
the children's perspective. Detailed values can be obtained
from Table 2.
Table 1 Baseline characteristics of participants by treatment group
TG WCG t / χ2 / U p
n=20 n=18
Mean age (SD) 9.11 (1.65) 9.66 (1.79) t=−.989 p=.329
Gender (female to male) 11 to 9 13 to 5 χ2=1.21 p=.272
(55.0 to 45.0 %) (72.2 to 27.8 %)
Duration of AP in months (SD) 30.45 (41.04) 39.22 (40.36) t=−.663 p=.511
Consultations of a physician in the last 3 months (SD) 1.06 (0.90) 1.97 (2.02) U=121.50 p=.303
Diagnosis according to Rome III
FAP (%) 14 of 20 (70.0 %) 15 of 18 (83.3 %) χ2=.932 p=.334
IBS (%) 6 of 20 (30.0 %) 3 of 18 (16.7 %)
Missed school days in the last 3 months
Never 10 of 20 (50.0 %) 7 of 18 (38.9 %) U=143.00 p=.290
1 day 6 of 20 (30.0 %) 4 of 18 (22.2 %)
2 to 7 days 4 of 20 (20.0 %) 5 of 18 (27.8 %)
More than a week 0 of 20 (0 %) 2 of 18 (11.1 %)
Pain characteristics (parental rating)
Common intensity of pain episodes in the last 3 months [1–10] (SD) 4.08 (1.34) 4.18 (1.35) t=−.229 p=.820
Maximum intensity of pain episodes in the last 3 months [1–10] (SD] 5.60 (1.82) 4.88 (1.73) t=1.22 p=.229
Common duration of pain episodes in the last 3 months [score 1–8] (SD) 3.45 (2.28) 3.39 (2.17) U=176.50 p=.919
API score of the last 2 weeks, z values (SD) 1.56 (2.90) 1.85 (2.98) t=−.305 p=.762
Pain characteristics (child's rating)
Number of recorded days with pain in diary [0–14] (SD) 7.90 (4.82) 9.50 (4.08) t=−1.10 p=.280
Mean intensity of pain episodes in diary [1–10] (SD) 4.18 (1.19) 5.03 (1.65) t=−1.83 p=.075
Mean duration score of pain episodes in diary [1–8] (SD) 3.40 (2.35) 3.50 (2.36) t=−.131 p=.897
Emotional/behavioral problems (parental rating)
CBCL internalizing T-score (SD) 67.00 (7.70) 67.28 (7.86) t=−.110 p=.913
CBCL externalizing T-score (SD) 55.75 (7.49) 56.50 (6.96) t=−.319 p=.752
CBCL total T-score (SD) 62.50 (7.83) 62.61 (7.80) t=−.044 p=.965
M mean, SD standard deviation, TG therapy group, WCG waitlist–control group, AP abdominal pain, FAP functional abdominal pain, IBS irritable
bowel syndrome, API abdominal pain index, CBCL Child Behavior Checklist 4/18
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A second multivariate analysis for the parent's perspec-
tive included also the variables which were found to be
significant in univariate analysis. As shown in Table 2, both
AP symptoms und pain-related disability still reached sig-
nificance regarding the time × group interaction in the
MANOVA, indicating a superiority of TG from the parent's
perspective in terms of AP symptoms and disability.
Discussion
The primary result of this study is that a brief hypnotherapeutic
and behavioral intervention (TG) was able to reduce the
pain frequency, pain duration, and pain intensity signifi-
cantly compared to a waiting list control group. The supe-
riority of the TG could be ascertained for children's and
parent's reports of the symptoms. Additionally, we could
demonstrate that children receiving the treatment showed a
significant stronger improvement of pain-related disability
compared the children who were waiting on the treatment
to start. Interestingly, the TG showed no superiority regard-
ing HRQoL from children's or parent's perspective. At
follow-up, the TG featured a high rate of treatment re-
sponders (55 %), whereas only one child of the WCG
improved to this extent. This result corresponds to the
finding by Vlieger and colleagues [48], who found a rate
of 59 % treatment response (>80 % improvement) after
3 months in a group of children and adolescents with FAP
or IBS receiving HT. Van Tilburg and colleagues reported
in their HT trial a treatment response rate (≥50 % im-
provement) of 63 % after 1 month and 63 % after
six months. On the one hand, the high rate of treatment
responders is remarkable since the majority of children
suffered from long-standing AP. On the other hand, this
is in line with previous research in adults, which has
shown that HT is highly effective in the treatment of adult
patients with severe IBS, who did not benefit from other
treatments [18].
Even though most children with frequent AP are
lacking explanatory organic diseases [1] and a substan-
tial proportion of children exhibits psychological prob-
lems [14, 17, 52], it cannot be concluded that frequent
nonorganic AP is caused by psychological factors [11].
FGIDs are thought to be strongly linked to a disordered
brain–gut interaction [13]: Stress and unpleasant emo-
tional states lead to hypervigilance and hence to an
increase of arousal of the autonomous nervous system
and the endocrine system, which may contribute to a
heightened sensitivity of the gut and modified gut mo-
tility [13, 31]. Additionally, persistent experiences of
pain may have an adverse effect on psychological
symptoms. The efficiency of psychotherapeutic treat-
ments [27] is probably caused by their modification of
this interplay of psychological and physiologic processes
(e.g., reduction of arousal and change of coping behavior).
HT aims to induce a hypnotic state (“trance”), which can
be achieved by deep relaxation or imagination and is
followed by direct and indirect suggestions. It is assumed
that persons in this state have a better ability to assimilate
new concepts about their problem [19], but the mechanisms
by which HT has an influence on FGIDs are not well
known. Till now, there is evidence (mainly from adults'
studies) that HT reduces autonomic reactivity [34], influ-
ences gut motility [57], and normalizes visceral sensitivity
[33]. In contrast, the only intervention study which exam-
ined a sample of children and adolescents with FAP or IBS
by physiological measures concluded that the symptom
reduction following HT could not be explained by relief of
visceral (rectal) sensitivity [50].
The behavioral elements of our intervention addressed the
parents' direct behavioral response on their children's somatic
complaints and the explanation of a biopsychosocial model.
Based on operant conditioning, parental reaction has a
notable influence on childhood AP [51, 56]. Therefore,
parents might contribute to a maladaptive role by showing
positive consequences to it. Other studies highlight the
importance of parental acceptance of a biopsychosocial
model for the explanation of the child's symptoms which
was associated with long-term symptom recovery [9, 37].
A three-session cognitive–behavioral intervention study by
Levy and coauthors [35] aimed mainly at modifying the
families' response on illness behavior of the child and
could demonstrate a long-lasting reduction of parent-
reported AP in a large sample. Beyond this, the empow-
erment of parents to take an active role in their child's
treatment might help to reduce helplessness and contribute
crucially to treatment success. However, it must be pointed
out that our combination of HT and behavioral interven-
tions did not allow drawing conclusions of which compo-
nents were effective and which were not.
We did not find an effect regarding HRQoL. This may be
due to the already high HRQoL values at baseline. Both
groups exhibited baseline values between 69 and 70 points
from both perspectives which is only one standard deviation
or less below the means of population [3]. As reported by
the children, only the TG improved between the two time
points but failed to reach significance. Parents in both con-
ditions reported a similar increase of HRQoL (6.6 or 8.4
points). A condition-specific measure for assessing HRQoL
might be more suitable.
The treatment gained a high compliance. No family
dropped out during the intervention, and all families
completed their follow-up measures. Previous results
showed a high acceptance of the treatment program
[22]. No adverse side effects were mentioned or
observed.
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A great strength of our concept is that the treatment is
very short, and that it is administered in small groups. This
makes it easy and cheap to implement. Although children
with AP are affected by this condition from months to years
[53], there is growing evidence of the efficiency of very
brief psychosocial interventions in treating AP [35, 47, 48].
This study delivers preliminary evidence that our stan-
dardized treatment is effective among children with long-
standing FAP or IBS, but there are also several limitations:
First, the control group was a wait-list control group and did
not receive an active treatment. The use of the wait-list
control group provides only evidence that the outcome of
the intervention (TG) is better than the natural course of AP
(WCG). Beyond this, a wait-list design does not control for
general therapeutic factors such as attention or expectation
of a future symptom improvement. The intervention should
be further evaluated against active interventions (e.g., chil-
dren's relaxation training or parental counseling). Second,
the wait-list design did not allow a more extended controlled
follow-up, and the long-term effect of the intervention is
unknown. Third, our sample sizes were too small for anal-
yses according to gender, age group, or Rome III diagnosis.
Further studies should consider comparing this interven-
tion to an active control group. Dismantling the components
of the treatment could additionally clear up which compo-
nents are effective and which are not. Measurement should
be supplemented by a condition-specific assessment of
HRQoL, the assessment of cognitive variables such as the
children's ability to cope with symptoms and by follow-up
assessment of psychopathology. Ambulatory recording of
psychophysiological variables (e.g., heart rate variability)
before and after treatment could contribute to figure out
potential mechanisms of action.
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